FDA will take 3 some-more months to examination diet pill

<p>WASHINGTON (AP) — Drugmaker Vivus Inc. pronounced Monday that regulators will take another 3 months to make a preference on a closely-watched plumpness drug Qnexa, that could turn a initial new medication weight loss tablet to strech a marketplace in some-more than a decade.
Vivus pronounced a Food and Drug Administration pushed behind a aim date to Jul 17 to cruise a new drug reserve devise submitted by a company. Previously a organisation was scheduled to make a preference by Apr 17. Vivus pronounced a three-month prolongation is customary when companies contention additional risk government information for a drug.
The FDA has deserted 3 initial drugs for plumpness in a final 3 years, including Qnexa, lifting questions about either any new weight detriment drugs can win approval. The organisation has not authorized a new medication diet tablet given 1999.
An effective and protected diet pill would expected be a blockbuster product in a U.S.: With some-more than 75 million po...